Acasti Pharma Inc. (CVE:ACST – Get Free Report) rose 1.8% on Tuesday . The company traded as high as C$0.58 and last traded at C$0.58. Approximately 2,450 shares changed hands during trading, a decline of 63% from the average daily volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Stock Up 1.8%
The business has a fifty day simple moving average of C$0.58 and a two-hundred day simple moving average of C$0.58. The company has a market capitalization of C$18.19 million, a price-to-earnings ratio of -1.21 and a beta of 1.22.
About Acasti Pharma
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Featured Stories
- Five stocks we like better than Acasti Pharma
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
